Literature DB >> 3403200

Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).

G Mohácsi1, A Magori, S Sonkodi.   

Abstract

The clinical course of 30 patients with idiopathic membranous glomerulonephritis has been followed up for 8.1 +/- 3.4 (4-17) years. First, in each case a long-term prednisone treatment was administered. During this therapy 12 (40%) patients improved and 9 had remission. In the 18 (60%) steroid resistant cases the treatment was combined with cytostatic drugs. After a combined regime for 1.9 +/- 0.8 years, 8 patients have improved, 2 of whom remitted. It has been suggested that due to a long-term immunomodulator therapy the level of urinary protein excretion might be reduced in 77% of patients. There was no effect of the applied treatment in 7% of cases, still in 16% a gradual deterioration was observed. Relapsing nephrotic syndrome has occurred in 3 (10%) of the total cases. Side effects requiring cessation of treatment were not observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403200     DOI: 10.1007/bf02549523

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

1.  Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis.

Authors:  A Saxon; R H Stevens; S J Ramer; P J Clements; D T Yu
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Controlled trial of cyclophosphamide in idiopathic membranous nephropathy.

Authors:  J V Donadio; K E Holley; C F Anderson; W F Taylor
Journal:  Kidney Int       Date:  1974-12       Impact factor: 10.612

3.  The clinical course of idiopathic membranous nephropathy.

Authors:  D T Erwin; J V Donadio; K E Holley
Journal:  Mayo Clin Proc       Date:  1973-10       Impact factor: 7.616

4.  Idiopathic membranous glomerulonephritis in adults: remission following steroid therapy.

Authors:  S P Rastogi; J Hart-Mercer; D N Kerr
Journal:  Q J Med       Date:  1969-07

5.  Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis.

Authors: 
Journal:  Can Med Assoc J       Date:  1976-12-18       Impact factor: 8.262

6.  Clinical membranous nephropathy.

Authors:  N P Mallick; C D Short; J Manos
Journal:  Nephron       Date:  1983       Impact factor: 2.847

7.  In situ immune complex formation and glomerular injury.

Authors:  W G Couser; D J Salant
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

8.  Treatment of idiopathic membranous nephropathy.

Authors:  T Ehrenreich; J G Porush; J Churg; L Garfinkel; S Glabman; M H Goldstein; E Grishman; S L Yunis
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

9.  Circulating immune complexes in idiopathic glomerular disease.

Authors:  S A Cairns; R A London; N P Mallick
Journal:  Kidney Int       Date:  1982-03       Impact factor: 10.612

10.  A controlled study of short-term prednisone treatment in adults with membranous nephropathy.

Authors: 
Journal:  N Engl J Med       Date:  1979-12-13       Impact factor: 91.245

View more
  1 in total

Review 1.  A novel link: in children, cow milk processing may be causative of idiopathic membranous nephropathy.

Authors:  Michael Haase; Anja Haase-Fielitz; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2011-12-20       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.